JP7490576B2 - 訓練された統計モデルを使用するマルチモーダル予測のための方法および装置 - Google Patents
訓練された統計モデルを使用するマルチモーダル予測のための方法および装置 Download PDFInfo
- Publication number
- JP7490576B2 JP7490576B2 JP2020566792A JP2020566792A JP7490576B2 JP 7490576 B2 JP7490576 B2 JP 7490576B2 JP 2020566792 A JP2020566792 A JP 2020566792A JP 2020566792 A JP2020566792 A JP 2020566792A JP 7490576 B2 JP7490576 B2 JP 7490576B2
- Authority
- JP
- Japan
- Prior art keywords
- modality
- data
- encoder
- drug
- training
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 279
- 238000013179 statistical model Methods 0.000 title claims description 178
- 239000013598 vector Substances 0.000 claims description 327
- 230000008569 process Effects 0.000 claims description 57
- 238000012545 processing Methods 0.000 claims description 9
- 238000012549 training Methods 0.000 description 367
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 289
- 201000010099 disease Diseases 0.000 description 287
- 229940079593 drug Drugs 0.000 description 257
- 239000003814 drug Substances 0.000 description 257
- 230000003993 interaction Effects 0.000 description 192
- 108090000623 proteins and genes Proteins 0.000 description 177
- 230000002068 genetic effect Effects 0.000 description 45
- 230000014509 gene expression Effects 0.000 description 24
- 230000006870 function Effects 0.000 description 20
- 238000003860 storage Methods 0.000 description 19
- 239000011159 matrix material Substances 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 13
- 210000003484 anatomy Anatomy 0.000 description 12
- 238000013507 mapping Methods 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 230000008236 biological pathway Effects 0.000 description 10
- 230000004913 activation Effects 0.000 description 9
- 238000005070 sampling Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 230000037361 pathway Effects 0.000 description 8
- 238000013528 artificial neural network Methods 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000003828 downregulation Effects 0.000 description 7
- 230000003827 upregulation Effects 0.000 description 7
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 206010025323 Lymphomas Diseases 0.000 description 5
- 101150097381 Mtor gene Proteins 0.000 description 5
- 108010029031 Regulatory-Associated Protein of mTOR Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000000090 biomarker Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 4
- 238000001647 drug administration Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000009274 differential gene expression Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002547 new drug Substances 0.000 description 3
- 241000252212 Danio rerio Species 0.000 description 2
- 229940124602 FDA-approved drug Drugs 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 2
- 101100174573 Homo sapiens PIKFYVE gene Proteins 0.000 description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 description 2
- 102100040969 Regulatory-associated protein of mTOR Human genes 0.000 description 2
- 206010038389 Renal cancer Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 201000010982 kidney cancer Diseases 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 108700019961 Neoplasm Genes Proteins 0.000 description 1
- 102000048850 Neoplasm Genes Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 230000004640 cellular pathway Effects 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000013135 deep learning Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000013090 high-throughput technology Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002705 metabolomic analysis Methods 0.000 description 1
- 230000001431 metabolomic effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 230000004879 molecular function Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/70—Machine learning, data mining or chemometrics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- Chemical & Material Sciences (AREA)
- Databases & Information Systems (AREA)
- Evolutionary Computation (AREA)
- Computing Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Crystallography & Structural Chemistry (AREA)
- Software Systems (AREA)
- Bioethics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Image Analysis (AREA)
- Complex Calculations (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862678083P | 2018-05-30 | 2018-05-30 | |
| US201862678094P | 2018-05-30 | 2018-05-30 | |
| US62/678,094 | 2018-05-30 | ||
| US62/678,083 | 2018-05-30 | ||
| PCT/US2019/031260 WO2019231624A2 (en) | 2018-05-30 | 2019-05-08 | Methods and apparatus for multi-modal prediction using a trained statistical model |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021526259A JP2021526259A (ja) | 2021-09-30 |
| JPWO2019231624A5 JPWO2019231624A5 (https=) | 2022-05-24 |
| JP2021526259A5 JP2021526259A5 (https=) | 2022-05-24 |
| JP7490576B2 true JP7490576B2 (ja) | 2024-05-27 |
Family
ID=66625356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566792A Active JP7490576B2 (ja) | 2018-05-30 | 2019-05-08 | 訓練された統計モデルを使用するマルチモーダル予測のための方法および装置 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3803884A2 (https=) |
| JP (1) | JP7490576B2 (https=) |
| KR (1) | KR20210018333A (https=) |
| CN (1) | CN112513990A (https=) |
| AU (1) | AU2019276730A1 (https=) |
| BR (1) | BR112020023429A2 (https=) |
| CA (1) | CA3100065A1 (https=) |
| MX (1) | MX2020012899A (https=) |
| WO (1) | WO2019231624A2 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201904887D0 (en) * | 2019-04-05 | 2019-05-22 | Lifebit Biotech Ltd | Lifebit al |
| JP7332238B2 (ja) * | 2020-03-10 | 2023-08-23 | エスアールアイ インターナショナル | タスク固有のデータ利用のための物理学により誘導されたディープマルチモーダル埋め込みのための方法及び装置 |
| CN111540405B (zh) * | 2020-04-29 | 2023-07-07 | 新疆大学 | 一种基于快速网络嵌入的疾病基因预测方法 |
| CN111627515B (zh) * | 2020-05-29 | 2023-07-18 | 上海商汤智能科技有限公司 | 药物推荐方法、装置、电子设备及介质 |
| WO2022006676A1 (en) * | 2020-07-09 | 2022-01-13 | Mcmaster University | Machine learning prediction of biological effect in multicellular animals from microorganism transcriptional fingerprint patterns in non-inhibitory chemical challenge |
| CN111950295A (zh) * | 2020-08-10 | 2020-11-17 | 北京嘀嘀无限科技发展有限公司 | 一种训练自然语言处理模型的方法和系统 |
| CN112151127A (zh) * | 2020-09-04 | 2020-12-29 | 牛张明 | 基于分子语义向量的无监督学习药物虚拟筛选方法和系统 |
| KR20230137869A (ko) * | 2020-09-25 | 2023-10-05 | 리누스 헬스 인코포레이티드 | 기계 학습 보조 인지 평가 및 치료를 위한 시스템들 및 방법들 |
| US11756572B2 (en) | 2020-12-02 | 2023-09-12 | Google Llc | Self-supervised speech representations for fake audio detection |
| CN112700277B (zh) * | 2020-12-30 | 2024-05-28 | 北京爱笔科技有限公司 | 用户行为数据的处理方法和多行为序列转化模型训练方法 |
| US12579111B2 (en) * | 2020-12-31 | 2026-03-17 | International Business Machines Corporation | Cross-domain structural mapping in machine learning processing |
| CN112862727B (zh) * | 2021-03-16 | 2023-06-23 | 上海壁仞智能科技有限公司 | 一种跨模态图像转换方法及装置 |
| CN113223655B (zh) * | 2021-05-07 | 2023-05-12 | 西安电子科技大学 | 基于变分自编码器的药物-疾病关联预测方法 |
| JP7674636B2 (ja) * | 2021-09-27 | 2025-05-12 | オムロン株式会社 | モデル生成方法、データ提示方法、データ生成方法、推定方法、モデル生成装置、データ提示装置、データ生成装置、及び推定装置 |
| CN113869417B (zh) * | 2021-09-28 | 2025-11-14 | 清华大学 | 基于自监督和多模态的基因数据模型训练方法及装置 |
| CN113987345A (zh) * | 2021-10-27 | 2022-01-28 | 北京百度网讯科技有限公司 | 数据处理的方法、装置、设备、存储介质及程序产品 |
| CN114049930B (zh) * | 2021-11-12 | 2024-07-16 | 东南大学 | 一种基于异质网络表示学习的中药药方重定位方法 |
| CN114429787B (zh) * | 2021-12-30 | 2023-04-18 | 北京百度网讯科技有限公司 | 组学数据处理方法、装置、电子设备和存储介质 |
| CN114334038B (zh) * | 2021-12-31 | 2024-05-14 | 杭州师范大学 | 一种基于异质网络嵌入模型的疾病药物预测方法 |
| CN114613450B (zh) * | 2022-03-09 | 2025-09-19 | 平安科技（深圳）有限公司 | 药物分子的性质预测方法、装置、存储介质及计算机设备 |
| CN114626480B (zh) * | 2022-03-22 | 2024-12-13 | 国网智能电网研究院有限公司 | 多源异构数据特征提取装置、方法、存储介质及电子设备 |
| WO2023193935A1 (en) * | 2022-04-08 | 2023-10-12 | NEC Laboratories Europe GmbH | Method and system for predicting gene expression perturbations |
| KR102841093B1 (ko) * | 2022-04-18 | 2025-07-31 | 한양대학교 산학협력단 | 모달리티의 고유 특성을 보존하는 멀티미디어 추천 방법 및 시스템 |
| CN114792573B (zh) * | 2022-04-18 | 2023-02-28 | 北京百度网讯科技有限公司 | 药物联用的效果预测方法、模型训练方法、装置及设备 |
| CN118158425A (zh) * | 2022-11-30 | 2024-06-07 | 华为技术有限公司 | 图像压缩系统、图像处理方法和编解码方法及电子设备 |
| CN115587257B (zh) * | 2022-12-13 | 2023-04-07 | 阿里巴巴（中国）有限公司 | 模型超参数优化方法、存储介质和电子设备 |
| KR20240108318A (ko) * | 2022-12-30 | 2024-07-09 | 건국대학교 글로컬산학협력단 | 머신 러닝 기반 메타 분석을 이용하여 계산된 일치된 가중치 연결 점수의 앙상블에 의한 신약 재창출 후보군 예측 방법 및 장치 |
| CN116524997B (zh) * | 2023-05-04 | 2024-07-16 | 电子科技大学 | 基于经典-量子混合神经网络实现药物相互作用结果的预测系统 |
| CN116244484B (zh) * | 2023-05-11 | 2023-08-08 | 山东大学 | 一种面向不平衡数据的联邦跨模态检索方法及系统 |
| WO2024263011A1 (ko) * | 2023-06-23 | 2024-12-26 | 주식회사 엘지 경영개발원 | 멀티태스킹 모델 학습 방법 및 이를 기초로 학습된 머신러닝 모델을 이용한 멀티태스킹 수행 방법 |
| WO2025015037A1 (en) * | 2023-07-10 | 2025-01-16 | Symphony Diagnostics, Inc. | Systems and methods for animal health assessment, surveillance, and enhancement |
| CN117133436A (zh) * | 2023-10-17 | 2023-11-28 | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 基于多源数据融合的药物疾病关联预测方法、装置及设备 |
| WO2025105524A1 (ko) * | 2023-11-15 | 2025-05-22 | 엘지전자 주식회사 | 인공 지능 서버 및 그의 동작 방법 |
| CN118352085B (zh) * | 2024-06-14 | 2024-09-17 | 之江实验室 | 基于多时间点多模态脑影像数据的脑疾病病程预测系统 |
| WO2026016189A1 (en) * | 2024-07-19 | 2026-01-22 | Antinous Technology Company Limited | Methylation transformer for cancer detection |
| WO2026076576A1 (en) * | 2024-10-08 | 2026-04-16 | Huawei Technologies Co., Ltd. | Devices and methods for in-network learning for dynamic wireless networks |
| CN119830148B (zh) * | 2024-11-14 | 2025-10-28 | 安徽理工大学 | 基于自监督空间学习的跨模态轴承故障诊断方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000310997A (ja) | 1999-03-09 | 2000-11-07 | Matsushita Electric Ind Co Ltd | 連結型音声合成のための単位重複領域の識別方法および連結型音声合成方法 |
| JP2010152751A (ja) | 2008-12-25 | 2010-07-08 | Nec Corp | 統計モデル学習装置、統計モデル学習方法、およびプログラム |
| JP2013211616A (ja) | 2012-03-30 | 2013-10-10 | Sony Corp | 端末装置、端末制御方法、プログラム、および情報処理システム |
| US20160170982A1 (en) | 2014-12-16 | 2016-06-16 | Yahoo! Inc. | Method and System for Joint Representations of Related Concepts |
| WO2017122785A1 (en) | 2016-01-15 | 2017-07-20 | Preferred Networks, Inc. | Systems and methods for multimodal generative machine learning |
| US20190197366A1 (en) | 2016-09-05 | 2019-06-27 | Kheiron Medical Technologies Ltd | Multi-modal medical image processing |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107545151B (zh) * | 2017-09-01 | 2020-10-16 | 中南大学 | 一种基于低秩矩阵填充的药物重定位方法 |
-
2019
- 2019-05-08 JP JP2020566792A patent/JP7490576B2/ja active Active
- 2019-05-08 AU AU2019276730A patent/AU2019276730A1/en not_active Abandoned
- 2019-05-08 BR BR112020023429-0A patent/BR112020023429A2/pt not_active Application Discontinuation
- 2019-05-08 MX MX2020012899A patent/MX2020012899A/es unknown
- 2019-05-08 WO PCT/US2019/031260 patent/WO2019231624A2/en not_active Ceased
- 2019-05-08 CN CN201980050949.3A patent/CN112513990A/zh active Pending
- 2019-05-08 EP EP19725548.2A patent/EP3803884A2/en not_active Withdrawn
- 2019-05-08 KR KR1020207037772A patent/KR20210018333A/ko not_active Ceased
- 2019-05-08 CA CA3100065A patent/CA3100065A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000310997A (ja) | 1999-03-09 | 2000-11-07 | Matsushita Electric Ind Co Ltd | 連結型音声合成のための単位重複領域の識別方法および連結型音声合成方法 |
| JP2010152751A (ja) | 2008-12-25 | 2010-07-08 | Nec Corp | 統計モデル学習装置、統計モデル学習方法、およびプログラム |
| JP2013211616A (ja) | 2012-03-30 | 2013-10-10 | Sony Corp | 端末装置、端末制御方法、プログラム、および情報処理システム |
| US20160170982A1 (en) | 2014-12-16 | 2016-06-16 | Yahoo! Inc. | Method and System for Joint Representations of Related Concepts |
| WO2017122785A1 (en) | 2016-01-15 | 2017-07-20 | Preferred Networks, Inc. | Systems and methods for multimodal generative machine learning |
| US20190197366A1 (en) | 2016-09-05 | 2019-06-27 | Kheiron Medical Technologies Ltd | Multi-modal medical image processing |
| JP2019530116A (ja) | 2016-09-05 | 2019-10-17 | ケイロン メディカル テクノロジーズ リミテッド | マルチモーダル医用画像処理 |
Non-Patent Citations (2)
| Title |
|---|
| NAPOLITANO Francesco et al.，Drug repositioning: a machine-learning approach through data integration，Journal of Cheminformatics volume 5, Article number: 30 (2013)，英国，BIOMED CENTRAL LTD, UK，2013年06月22日，volume 5, Article number: 30 (2013)，pp.1-9，［令和 5年4月24日検索］，インターネット ＜URL：https://jcheminf.biomedcentral.com/counter/pdf/10.1186/1758-2946-5-30.pdf＞，ISSN: 1758-2946、DOI: https://doi.org/10.1186/1758-2946-5-30, |
| Zhang, Ping et al.，Towards Drug Repositioning: A Unified Computational Framework for Integrating Multiple Aspects of Drug Similarity and Disease Similarity，AMIA Annual Symposium Proceedings 2014，米国，AMIA，2014年11月14日，pp.1258-1267，［令和 5年4月24日検索］，インターネット ＜URL：https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419869/＞ |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3100065A1 (en) | 2019-12-05 |
| EP3803884A2 (en) | 2021-04-14 |
| WO2019231624A3 (en) | 2020-03-19 |
| AU2019276730A1 (en) | 2020-12-10 |
| KR20210018333A (ko) | 2021-02-17 |
| MX2020012899A (es) | 2021-02-26 |
| BR112020023429A2 (pt) | 2021-02-23 |
| JP2021526259A (ja) | 2021-09-30 |
| WO2019231624A2 (en) | 2019-12-05 |
| CN112513990A (zh) | 2021-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7490576B2 (ja) | 訓練された統計モデルを使用するマルチモーダル予測のための方法および装置 | |
| US20240296206A1 (en) | Methods and apparatus for multi-modal prediction using a trained statistical model | |
| US20240420850A1 (en) | Methods and apparatus for making biological predictions using a trained multi-modal statistical model | |
| Gao et al. | KG-Predict: A knowledge graph computational framework for drug repurposing | |
| Lopez-Garcia et al. | Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data | |
| Yaqoob et al. | Optimizing gene selection and cancer classification with hybrid sine cosine and cuckoo search algorithm | |
| Zhang et al. | Review of the applications of deep learning in bioinformatics | |
| WO2017122785A1 (en) | Systems and methods for multimodal generative machine learning | |
| Zou et al. | Approaches for recognizing disease genes based on network | |
| Ceci et al. | Semi-supervised multi-view learning for gene network reconstruction | |
| Teng et al. | Adaptive feature selection using v-shaped binary particle swarm optimization | |
| Sławek et al. | ENNET: inferring large gene regulatory networks from expression data using gradient boosting | |
| CN116230070A (zh) | 一种转录因子靶基因关系预测方法、系统、设备和介质 | |
| US20230253076A1 (en) | Local steps in latent space and descriptors-based molecules filtering for conditional molecular generation | |
| Coates et al. | Radiomic and radiogenomic modeling for radiotherapy: strategies, pitfalls, and challenges | |
| Kowald et al. | Transfer learning of clinical outcomes from preclinical molecular data, principles and perspectives | |
| Mahmoud et al. | Breast cancer survival prediction modeling based on genomic data: An improved prognosis-driven deep learning approach | |
| Li et al. | MIFAM-DTI: a drug-target interactions predicting model based on multi-source information fusion and attention mechanism | |
| Thapa et al. | Strategies to include prior knowledge in omics analysis with deep neural networks | |
| Gulande et al. | A hybrid mRMR-RSA feature selection approach for lung cancer diagnosis using gene expression data | |
| CN121237367A (zh) | 基于注意力机制的多模态数据处理方法、装置、设备及介质 | |
| CN116981779B (zh) | 用于从Hi-C矩阵识别染色质结构特征的方法、存储用于从Hi-C矩阵中识别染色质结构特征的程序的非瞬态计算机可读介质 | |
| Moore et al. | Genetic analysis of prostate cancer using computational evolution, pareto-optimization and post-processing | |
| Lee et al. | The estimation of probability distribution for factor variables with many categorical values | |
| Tong | Enabling precision medicine by integrating multi-modal biomedical data |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220506 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220506 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220516 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230718 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231018 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240117 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240430 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240515 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7490576 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |